Clinical Trials Insight: 700028884
Phase of Trial: Phase I
Latest Information Update: 04 Dec 2013
At a glance
- Drugs Auriclosene (Primary)
- Indications Conjunctivitis; Otorhinolaryngological infections; Staphylococcal infections; Urinary tract infections
- Focus Adverse reactions
- Sponsors NovaBay Pharmaceuticals
- 04 Dec 2013
- 11 Mar 2008 Status changed from recruiting to completed, as reported in a NovaBay media release.
- 28 Nov 2007 New trial record.